scispace - formally typeset
L

Lei Feng

Researcher at Dalian Medical University

Publications -  126
Citations -  2633

Lei Feng is an academic researcher from Dalian Medical University. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 23, co-authored 108 publications receiving 1738 citations. Previous affiliations of Lei Feng include University of Bath & Henan Normal University.

Papers
More filters
Journal ArticleDOI

A Highly Selective Ratiometric Two-Photon Fluorescent Probe for Human Cytochrome P450 1A.

TL;DR: A two-photon excited ratiometric fluorescent probe NCMN has been developed and well-characterized for sensitive and selective detection of CYP1A, which holds great promise for bioimaging of endogenous CYp1A in living cells and for further investigation on CYP 1A associated biological functions in complex biological systems.
Journal ArticleDOI

Molecular Design Strategy to Construct the Near-Infrared Fluorescent Probe for Selectively Sensing Human Cytochrome P450 2J2

TL;DR: BnXPI was successfully used to monitor CYP2J2 activity in real-time for various living systems including cells, tumor tissues, and tumor-bearing animals and displayed the best combination of specificity, sensitivity and applicability for detecting CYP 2J2 in vitro and in vivo.
Journal ArticleDOI

A Two-Photon Ratiometric Fluorescent Probe for Imaging Carboxylesterase 2 in Living Cells and Tissues.

TL;DR: A two-photon ratiometric fluorescent probe NCEN designed and developed for highly selective and sensitive sensing of human carboxylesterase 2 (hCE2) based on the catalytic properties and substrate preference showed great promise for applications in bioimaging of endogenous h CE2 in living cells and in exploring the biological functions of hCE2 in complex biological systems.
Journal ArticleDOI

A highly selective near-infrared fluorescent probe for carboxylesterase 2 and its bioimaging applications in living cells and animals

TL;DR: The DDAB probe has been successfully used to detect endogenous CE2 in living cells and in vivo for the first time, and the results demonstrate that such detection is highly reliable.
Journal ArticleDOI

Andrographolide inhibits breast cancer through suppressing COX-2 expression and angiogenesis via inactivation of p300 signaling and VEGF pathway

TL;DR: The potential anti-cancer effects of Andro are demonstrated, indicating that Andro could inhibit COX-2 expression through attenuating p300 HAT activity and suppress angiogenesis via VEGF pathway, and thereby could be developed as an antitumor agent for the treatment of breast cancer.